What is the appropriate intramuscular dose of lorazepam (Ativan) for an adult patient?

Ativan IM Dose for Adults

For adult patients, the appropriate intramuscular dose of lorazepam (Ativan) is 0.05 mg/kg, with a maximum single dose of 4 mg. 1

Standard Dosing Guidelines

The most commonly cited IM dosing across multiple clinical guidelines is:

• Standard adult dose: 2 mg IM 1
• Weight-based dosing: 0.05-0.1 mg/kg IM 1
• Psychosis with agitation: 0.05-0.15 mg/kg IM (maximum single dose: 5 mg) 2
• May repeat every 30-60 minutes as needed 1

Clinical Context and Timing

Onset and Duration:

• Onset of action: 15-20 minutes IM 1
• Peak effect: 1-2 hours IM 1
• Duration: 6-8 hours 1

This delayed onset is clinically important—lorazepam IM works more slowly than IV administration, which has onset in 5-10 minutes 1.

Special Populations

Elderly, frail, or patients with COPD:

• Use lower doses: 0.25-0.5 mg IM 3
• Particularly important when co-administered with antipsychotics due to increased risk of oversedation and respiratory depression 3

Cancer patients with delirium:

• Starting dose: 1 mg subcutaneous or IV stat (up to 2 mg maximum) 3
• Can also be given IM, PO, or sublingual 3

Critical Safety Considerations

Respiratory monitoring is mandatory:

• Increased risk of apnea when combined with other sedative agents 2
• Be prepared to provide respiratory support regardless of route 2
• Monitor oxygen saturation continuously 2

Common pitfall: The IM route has been associated with pain at injection site and restlessness persisting 20-40 minutes 4. Despite faster onset than oral administration, these adverse effects may offset the benefit of IM injection 4.

Contraindications:

• Use with extreme caution in patients with respiratory compromise 1
• Severe pulmonary insufficiency, severe liver disease, myasthenia gravis 3

Reversal Agent

Flumazenil may reverse life-threatening respiratory depression, but it will also counteract anticonvulsant effects and may precipitate seizure recurrence 2. Use with extreme caution in benzodiazepine-dependent patients as it may precipitate acute withdrawal 2.

Practical Considerations

The 4 mg IM dose has been extensively studied as preoperative medication and was found to be optimal for patients averaging 60 kg body weight 4. However, this dose produces prolonged drowsiness lasting at least 4 hours and significant anterograde amnesia 4.

For acute agitation management, the 2 mg IM dose can be repeated every 30-60 minutes based on clinical response 1, but cumulative sedation and respiratory depression risk increases with repeated dosing.